Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Copper Catalyzed Michael Addition. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel copper-catalyzed route avoids palladium and SFC resolution. Reduces cost and enhances supply chain reliability for pharmaceutical intermediates.
Patent CN108822101B reveals a high-yield Michael addition route for benzhydryl quinuclidinone, offering cost reduction and scalable production for veterinary APIs.